Scientists test personalized vaccine to fight Alzheimer's in the brain
NCT ID NCT05834296
Summary
This early-stage study is testing a new, personalized cell therapy designed to train the body's immune system to fight Alzheimer's disease. Doctors take a patient's own immune cells, load them with a modified Alzheimer's-related protein, and inject them back to potentially trigger a protective response. The main goals are to check if the treatment is safe and to find the right dose for future, larger studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Excellent Research Group
Doral, Florida, 33186, United States
Conditions
Explore the condition pages connected to this study.